Foghorn’s AML/MDS Trial Moved From Partial To Full Clinical Hold
Uveal Melanoma Study Continues
A Phase I clinical trial of Foghorn’s FHD-286, which was placed on a partial hold in May after one death, is on a full hold now that multiple deaths may be attributed to differentiation syndrome.
